Academic authorship of academic journal manuscript, books, and other original works is a means by which academia communicate the results of their scholarly work, establish priority for their discoveries, and build their reputation among their peers. Through authorship, researchers, assistants, interns, students, and other involved parties (e.g., Citizen science, academic consortia) receive credit for their contributions and can be held responsible and accountable for the quality and integrity of the work.
Authorship is a primary basis that employers use to evaluate academic personnel for employment, promotion, and tenure. In academic publishing, authorship of a work is typically claimed by those making intellectual contributions to the research described in the work. However, many scholarly journals also require that potential authors contribute to the writing of the article about the work, not just the work itself. Such requirements, as well as other norms around authorship in disciplines, can be controversial. In these contexts, authorship can encompass activities other than writing the article; a researcher who comes up with an experimental design and analyzes the data may be considered an author, even if she or he had little role in composing the text describing the results. According to some standards, even writing the entire article would not constitute authorship unless the writer was also involved in at least one other phase of the project.
Acquisition of funding, or general supervision of the research group alone does not constitute authorship. Biomedical authorship is prone to various misconducts and disputes. Many authors – especially those in the middle of the byline – do not fulfill these authorship criteria. Some medical journals have abandoned the strict notion of author, with the flexible notion of contributor.
In particular types of research, including particle physics, genome sequencing and clinical trials, a paper's author list can run into the hundreds, referred to as "hyperauthorship". In 1998, the Collider Detector at Fermilab (CDF) adopted a (at that time) highly unorthodox policy for assigning authorship. CDF maintains a standard author list. All scientists and engineers working at CDF are added to the standard author list after one year of full-time work; names stay on the list until one year after the worker leaves CDF. Every publication coming out of CDF uses the entire standard author list, in alphabetical order. Other big collaborations, including most particle physics experiments, followed this model.
In large, multi-center clinical trials authorship is often used as a reward for recruiting patients. A paper published in the New England Journal of Medicine in 1993 reported on a clinical trial conducted in 1,081 hospitals in 15 different countries, involving a total of 41,021 patients. There were 972 authors listed in an appendix and authorship was assigned to a group. In 2015, an article in high-energy physics was published describing the measurement of the mass of the Higgs boson based on collisions in the Large Hadron Collider; the article boasted 5,154 authors, the printed author list needed 24 pages.
Large authors lists have attracted some criticism and are believed to negatively affect all existing ethical issues of authorship. They strain guidelines that insist that each author's role be described and that each author is responsible for the validity of the whole work. Such a system treats authorship more as credit for scientific service at the facility in general rather that as an identification of specific contributions.Biagioli, M. Rights or rewards? Changing frameworks of scientific authorship. In Scientific Authorship, Biagioli, M. and Galison, P. eds. Routledge, New York, 2003, pp. 253–280. One commentator wrote, "In more than 25 years working as a scientific editor ... I have not been aware of any valid argument for more than three authors per paper, although I recognize that this may not be true for every field." The rise of shared authorship has been attributed to Big Science—scientific experiments that require collaboration and specialization of many individuals.
Alternatively, the increase in multi-authorship is according to a Game theory analysis a consequence of the way scientists are evaluated. Scientists are judged by the number of papers they publish, and by the impact of those papers. Both measures are integrated into the most popular single value measure h-index. The -index correlates with winning the Nobel Prize, being accepted for research fellowships and holding positions at top universities. When each author claims each paper and each citation as his/her own, papers and citations are multiplied by the number of authors. Since it is common and rational to cite own papers more than others, a high number of coauthors increases not only the number of own papers, but also their impact. As result, game rules set by -index being a decision criterion for success create a zero-sum -index ranking game, where the rational strategy includes maximizing the number of coauthors up to the majority of the researchers in a field. Data of 189 thousand publications showed that the coauthors' number is strongly correlated with -index. Hence, the system rewards heavily multi-authored papers. This problem is openly acknowledged, and it could easily be "corrected" by dividing each paper and its citations by the number of authors, though this practice has not been widely adopted.
Finally, the rise in shared authorship may also reflect increased acknowledgment of the contributions of lower level workers, including graduate students and technicians, as well as honorary authorship, while allowing for such collaborations to make an independent statement about the quality and integrity of a scientific work.
Although listing authors in order of the involvement in the project seems straightforward, it often leads to conflict. A study in the Canadian Medical Association Journal found that more than two-thirds of 919 corresponding authors disagreed with their coauthors regarding contributions of each author.
In a notable case, American stem-cell researcher Gerald Schatten had his name listed on a paper co-authored with Hwang Woo-suk. The paper was later exposed as fraudulent and, though Schatten was not accused of participating in the fraud, a panel at his university found that "his failure to more closely oversee research with his name on it does make him guilty of 'research misbehavior.'"Holden, Constance. (2006.) Schatten: Pitt Panel Finds "Misbehavior" but Not Misconduct. Science, 311:928.
All authors, including co-authors, are usually expected to have made reasonable attempts to check findings submitted for publication. In some cases, co-authors of faked research have been accused of inappropriate behavior or research misconduct for failing to verify reports authored by others or by a commercial sponsor. Examples include the case of Professor Geoffrey Chamberlain named as guest author of papers fabricated by Malcolm Pearce, (Chamberlain was exonerated from collusion in Pearce's deception) and the co-authors of Jan Hendrik Schön at Bell Labs. More recent cases include Charles Nemeroff, former editor-in-chief of Neuropsychopharmacology, and the so-called Sheffield Actonel affair.
Additionally, authors are expected to keep all study data for later examination even after publication. Both scientific and academic censure can result from a failure to keep primary data; the case of Ranjit Chandra of Memorial University of Newfoundland provides an example of this. Many scientific journals also require that authors provide information to allow readers to determine whether the authors may have commercial or non-commercial conflicts of interest. Outlined in the author disclosure statement for the American Journal of Human Biology, this is a policy more common in scientific fields where funding often comes from corporate sources. Authors are also commonly required to provide information about research ethics aspects of research, particularly where research involves human or animal participants or use of biological material. Provision of incorrect information to journals may be regarded as misconduct. Financial pressures on universities have encouraged this type of misconduct. The majority of recent cases of alleged misconduct involving undisclosed conflicts of interest or failure of the authors to have seen scientific data involve collaborative research between scientists and biotechnology companies.
A possible measure against honorary authorships has been implemented by some scientific journals, in particular by the Nature journals. They demand that each new manuscript must include a statement of responsibility that specifies the contribution of every author. The level of detail varies between the disciplines. Senior persons may still make some vague claim to have "supervised the project", for example, even if they were only in the formal position of a supervisor without having delivered concrete contributions. (The truth content of such statements is usually not checked by independent persons.) However, the need to describe contributions can at least be expected to somewhat reduce honorary authorships. In addition, it may help to identify the perpetrator in a case of scientific fraud.
Guest authors are those that are included with the specific objective to increase the probability that it becomes accepted by a journal. A rolling authorship is a special case of gift authorship in which the honor is granted on the basis of previous research papers (published or not) and collaborations within the same research group. The "rolled" author may (or may not) be imposed by a superior employee for reasons that range from the research group's strategic interests, personal career interests, camaraderie or (professional) concession. For instance, a post-doc researcher in the same research group where his PhD was awarded, may be willing to roll his authorship into any subsequent paper from other researchers in that same group, overseeing the criteria for authorship. Per se, this would not cause authorship issues unless the collaboration was imposed by a third party, like a supervisor or department manager, in which case it is called a coercive authorship. Still, omitting the authorship criteria by prioritizing hierarchy arguments, is an unethical practice. This kind of practices may hinder free-thinking and professional independence, and thus should be tackled by research managers, clear research guidelines and authors agreements.
Ghost authorship has been linked to partnerships between industry and higher education. Two-thirds of industry-initiated randomized trials may have evidence of ghost authorship. Ghost authorship is considered problematic because it may be used to obscure the participation of researchers with conflicts of interest.
Litigation against the pharmaceutical company, Merck over health concerns related to use of their drug, Rofecoxib (brand name Vioxx), revealed examples of ghost authorship. Merck routinely paid medical writing companies to prepare journal manuscripts, and subsequently recruited external, academically affiliated researchers to pose as the authors.
Authors are sometimes included in a list without their permission. Even if this is done with the benign intention to acknowledge some contributions, it is problematic since authors carry responsibility for correctness and thus need to have the opportunity to check the manuscript and possibly demand changes.
In the 18th century, Émilie du Châtelet began her career as a scientific author by submitting a paper in an annual competition held by the French Academy of Sciences; papers in this competition were submitted anonymously. Initially presenting her work without claiming authorship allowed her to have her work judged by established scientists while avoiding the bias against women in the sciences. She did not win the competition, but eventually her paper was published alongside the winning submissions, under her real name.Terrall, M. The uses of anonymity in the age of reason. In Scientific Authorship Biagioli, M. and Galison, P. eds. Routledge, New York, 2003, pp. 91–112.
Scientists and engineers working in corporate and military organizations are often restricted from publishing and claiming authorship of their work because their results are considered secret property of the organization that employs them. One notable example is that of William Sealy Gosset, who was forced to publish his work in statistics under the pseudonym "Student" due to his employment at the Guinness brewery. Another account describes the frustration of physicists working in nuclear weapons programs at the Lawrence Livermore Laboratory – years after making a discovery they would read of the same phenomenon being "discovered" by a physicist unaware of the original, secret discovery of the phenomenon.Gusterson, H. The death of the authors of death – Prestige and creativity among nuclear weapons scientists. In Scientific Authorship Biagioli, M. and Galison, P. eds. Routledge, New York, 2003, pp. 282–307.
Satoshi Nakamoto is a pseudonym of a still unknown author or authors' group behind a white paper about bitcoin.
Artificial intelligence systems have been credited with authorship on a handful of academic publications, however, many publishers disallow this on the grounds that "they cannot take responsibility for the content and integrity of scientific papers". Instead, most academic journals require authors to disclose use of AI assistance in the acknowledgements or a special section of the paper.
Order of authors in a list
Responsibilities of authors
Egregious and questionable types of authorship
Honorary authorship
Gift, guest and rolling authorship
Ghost authorship
Fraudulent paid-for authorship
Unconventional types of authorship
Anonymous and unclaimed authorship
Group authorship
Equal co-authorship
Non-human authorship
See also
Further reading
|
|